Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEAT: Etonogestrel Implant for Failed Endometrial Ablation
NCT05227456Phase 2Withdrawn
- Sponsor
- Saskatchewan Health Authority
- Start
- Jul 2022
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of etonogestrel in abnormal uterine bleeding (AUB), dysmenorrhea, sponsored by Saskatchewan Health Authority. Planned start Jul 2022; status: withdrawn.
02
Drugs
etonogestrel
03
Conditions
abnormal uterine bleeding (AUB)dysmenorrhea
Beyond the preview
Go deeper on NCT05227456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05227456.